US FDA Advisory Committee Open Public Hearing Changes Urged

 
• By Sue Sutter
Microphone
Stakeholders disagree about the shortfalls in the existing open public hearing process. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers